• By ICR Secretariat
  • Posted Monday, April 17, 2023

Biotech fears ‘dangerous’ precedent as judge challenges FDA authority


A federal judge’s decision to revoke the approval of an abortion pill rippled across the biotechnology industry over the weekend, as industry leaders warned the ruling could threaten the Food and Drug Administration’s authority to regulate medicines.